Thousands” of complaints about the volume of TV commercials have flooded the Federal Communications Commission (FCC) in ...

Celebrity red carpet appearances at the SAG Awards have reignited concerns about their noticeably slimmer figures and fueled ...

Eli Lilly's bet on the Oscars shows the GLP-1 ad wars are heating up. - Eli Lilly. At the 2024 Academy Awards, Eli Lilly, the ...

The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...

Hims & Hers (HIMS) made a killing last year selling an off-brand version of Ozempic, but with the drug’s shortage now over, ...

Medicare Part D spending for 10 selected diabetes drugs in the USA totaled $35.8 billion in 2023, an increase of 364% from ...

Financial markets grappled with a storm of political maneuvering around trade, taxes, and regulation, stoking some investor ...

After the FDA removed semaglutide injection products from a shortage list, compounders like Hims have 60-90 days to stop ...

Celebrities have been thin on the ground in Milan, in part thanks to fashion week’s conjunction with the Oscars, but a group ...

Altimmune's pemvidutide shows promise in treating MASH and obesity, with upcoming Phase 2b results poised to shape its market ...

The FDA has resolved the shortage of Wegovy and Ozempic, but companies like Hims and Hers may halt sales of compounded ...